On August 18, 2015, the U.S. Food and Drug Administration (FDA) approved flibanserin: the first and only medication for the treatment of distressing low desire or Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
What is HSDD?
Hypoactive Sexual Desire Disorder (HSDD) is a medical condition recognized since 1977. It’s the most common form of female sexual dysfunction. HSDD is defined as the persistent loss …
Welcome to our breast reconstruction Q&A blog series with Scott Sullivan, M.D., F.A.C.S. of the Center for Restorative Breast Surgery in New Orleans, LA. In this installment, Dr. Sullivan compares implant reconstruction with reconstruction using your own tissues (flap reconstruction).
Read Dr. Sullivan’s Q&A on Flap Reconstruction.
Read Dr. Sullivan’s Q&A on Implant Reconstruction.
How do you know whether implant reconstruction is …